Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer (Q40608619)
Jump to navigation
Jump to search
scientific article published on January 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer |
scientific article published on January 2001 |
Statements
1 reference
Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer (English)
1 reference
M A Rudek
1 reference
W D Figg
1 reference
V Dyer
1 reference
W Dahut
1 reference
M L Turner
1 reference
S M Steinberg
1 reference
D J Liewehr
1 reference
D R Kohler
1 reference
J M Pluda
1 reference
E Reed
1 reference
1 January 2001
1 reference
1 reference
19
1 reference
2
1 reference
584-592
1 reference
Identifiers
1 reference
1 reference